Benepali® PEN Patient Satisfaction Survey

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

June 21, 2018

Study Completion Date

June 21, 2018

Conditions
Rheumatoid ArthritisSpondyloarthropathies
Interventions
BIOLOGICAL

Benepali

Administered as specified in the treatment arm.

Trial Locations (38)

10117

Research Site, Berlin

10719

Research Site, Berlin

12435

Research Site, Berlin

12555

Research Site, Berlin

13055

Research Site, Berlin

13353

Research Site, Berlin

22767

Research Site, Hamburg

22844

Research Site, Norderstedt

24161

Research Site, Altenholz

35392

Research Site, Giessen

35630

Research Site, Ehringshausen

38100

Research Site, Braunschweig

38723

Research Site, Seesen

39104

Research Site, Magdeburg

40211

Research Site, Düsseldorf

41462

Research Site, Neuss

45326

Research Site, Essen

50825

Research Site, Cologne

52428

Research Site, Jülich

53474

Research Site, Bad Neuenahr-Ahrweiler

66111

Research Site, Saarbrücken

66424

Research Site, Homburg

67069

Research Site, Ludwigshafen

72072

Research Site, Tübingen

73033

Research Site, Göpping

77652

Research Site, Offenberg

80639

Research Site, München

89073

Research Site, Ulm

90443

Research Site, Nuremberg

96317

Research Site, Kronach

96450

Research Site, Coburg

99096

Research Site, Erfurt

01109

Research Site, Dresden

06128

Research Site, Halle

04109

Research Site, Leipzig

04129

Research Site, Leipzig

06343

Research Site, Mansfeld

02763

Research Site, Mittelherwigsdorf

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY